Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation

American Journal of Ophthalmology

Volumn 159, Issue 2, 2015, Pages 285-292.e1

  Cho, Han Joo ^a   Yoo, Seul Gi ^a   Kim, Hyoung Seok ^a   Kim, Jae Hui ^a   Kim, Chul Gu ^a   Lee, Tae Gon ^a   Kim, Jong Woo ^a  

^a Konyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; COLORING AGENT; INDOCYANINE GREEN; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CORNEA THICKNESS; DRUSEN; ENDOPHTHALMITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LENS DISEASE; LOADING DRUG DOSE; MALE; OUTCOME ASSESSMENT; RETINA DETACHMENT; RETINAL ANGIOMATOUS PROLIFERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DIAGNOSTIC USE; INTERVENTION STUDY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR DEGENERATION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGY; RETINAL NEOVASCULARIZATION; RISK FACTOR; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GEOGRAPHIC ATROPHY; HUMANS; INDOCYANINE GREEN; INTERVENTION STUDIES; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL NEOVASCULARIZATION; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84919787314     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2014.10.035     Document Type: Article

References (30)

1. L.A. Yannuzzi, S. Negrão, and T. Iida Retinal angiomatous proliferation in age-related macular degeneration Retina 21 5 2001 416 434
2. I. Maruko, T. Iida, M. Saito, D. Nagayama, and K. Saito Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 1 2007 15 22
3. S.Y. Cohen, C. Creuzot-Garcher, and J. Darmon Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration Br J Ophthalmol 91 9 2007 1173 1176
4. M. Gharbiya, F. Allievi, V. Recupero, D. Martini, L. Mazzeo, and C.B. Gabrieli Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results Retina 29 6 2009 740 749
5. K. Atmani, M. Voigt, and V. Le Tien Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration Eye (Lond) 24 7 2010 1193 1198
6. M.B. Parodi, P. Iacono, and F. Menchini Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation Acta Ophthalmol 91 3 2013 267 273
7. P.J. Rosenfeld, H. Shapiro, and L. Tuomi Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Ophthalmology 118 3 2011 523 530
8. J.E. Grunwald, E. Daniel, and G.S. Ying Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology 119 8 2012 1634 1641
9. G.J. Jaffe, D.F. Martin, and C.A. Toth Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials Ophthalmology 120 9 2013 1860 1870
10. J.E. Grunwald, E. Daniel, and J. Huang Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology 121 1 2014 150 161
11. V.A. McBain, R. Kumari, J. Townend, and N. Lois Geographic atrophy in retinal angiomatous proliferation Retina 31 6 2011 1043 1052
12. M. Inoue, A. Arakawa, S. Yamane, and K. Kadonosono Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography Br J Ophthalmol 98 7 2014 956 960
13. N. Ueda-Arakawa, S. Ooto, A. Tsujikawa, K. Yamashiro, A. Oishi, and N. Yoshimura Sensitivity and specificity of detecting reticular pseudodrusen in multimodal imaging in Japanese patients Retina 33 3 2013 490 497
14. W.B. Wei, L. Xu, and J.B. Jonas Subfoveal choroidal thickness: the Beijing Eye Study Ophthalmology 120 1 2013 175 180
15. L. Shao, L. Xu, and C.X. Chen Reproducibility of subfoveal choroidal thickness measurements with enhanced depth imaging by spectral-domain optical coherence tomography Invest Ophthalmol Vis Sci 54 1 2013 230 233
16. C.J. Boon, J.P. van de Ven, C.B. Hoyng, A.I. den Hollander, and B.J. Klevering Cuticular drusen: stars in the sky Prog Retin Eye Res 37 2013 90 113
17. F.G. Holz, E.C. Strauss, S. Schmitz-Valckenberg, and M. van Lookeren Campagne Geographic atrophy: clinical features and potential therapeutic approaches Ophthalmology 121 5 2014 1079 1091
18. H.S. Brader, G.S. Ying, E.R. Martin, and M.G. Maguire Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial Ophthalmology 120 9 2013 1871 1879
19. M. Saint-Geniez, T. Kurihara, E. Sekiyama, A.E. Maldonado, and P.A. D'Amore An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris Proc Natl Acad Sci U S A 106 44 2009 18751 18756
20. D.L. Nickla, and J. Wallman The multifunctional choroid Prog Retin Eye Res 29 2 2010 144 168
21. U. Chakravarthy, S.P. Harding, and C.A. Rogers Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial Lancet 382 9900 2013 1258 1267
22. N. Ueda-Arakawa, S. Ooto, and I. Nakata Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration Am J Ophthalmol 155 2 2013 260 269
23. J.H. Kim, J.R. Kim, S.W. Kang, S.J. Kim, and H.S. Ha Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration Am J Ophthalmol 155 4 2013 743 749
24. J.Y. Lee, D.H. Lee, and Y.H. Yoon Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration Invest Ophthalmol Vis Sci 54 12 2013 7812 7818
25. R.T. Smith, M.A. Sohrab, M. Busuioc, and G. Barile Reticular macular disease Am J Ophthalmol 148 5 2009 733 743
26. J.J. Arnold, S.H. Sarks, M.C. Killingsworth, and J.P. Sarks Reticular pseudodrusen. A risk factor in age-related maculopathy Retina 15 3 1995 183 191
27. G. Querques, L. Querques, R. Forte, N. Massamba, F. Coscas, and E.H. Souied Choroidal changes associated with reticular pseudodrusen Invest Ophthalmol Vis Sci 53 3 2012 1258 1263
28. N. Ueda-Arakawa, S. Ooto, and A.A. Ellabban Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography Am J Ophthalmol 157 5 2014 994 1004
29. M. Sawa, C. Ueno, F. Gomi, and K. Nishida Incidence and characteristics of neovascularization in fellow eyes of Japanese patients with unilateral retinal angiomatous proliferation Retina 34 4 2014 761 767
30. D.F. Martin, M.G. Maguire, and S.L. Fine Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398